IBDEI15H ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20551,1,3,0)
 ;;=3^Topotecan Inj 0.1mg
 ;;^UTILITY(U,$J,358.3,20552,0)
 ;;=J9035^^116^1243^12^^^^1
 ;;^UTILITY(U,$J,358.3,20552,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20552,1,1,0)
 ;;=1^J9035
 ;;^UTILITY(U,$J,358.3,20552,1,3,0)
 ;;=3^Bevacizumab Inj 10mg
 ;;^UTILITY(U,$J,358.3,20553,0)
 ;;=J9041^^116^1243^14^^^^1
 ;;^UTILITY(U,$J,358.3,20553,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20553,1,1,0)
 ;;=1^J9041
 ;;^UTILITY(U,$J,358.3,20553,1,3,0)
 ;;=3^Bortezomib Inj 0.1mg
 ;;^UTILITY(U,$J,358.3,20554,0)
 ;;=J9055^^116^1243^18^^^^1
 ;;^UTILITY(U,$J,358.3,20554,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20554,1,1,0)
 ;;=1^J9055
 ;;^UTILITY(U,$J,358.3,20554,1,3,0)
 ;;=3^Cetuximab Inj 10mg
 ;;^UTILITY(U,$J,358.3,20555,0)
 ;;=J8530^^116^1243^22^^^^1
 ;;^UTILITY(U,$J,358.3,20555,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20555,1,1,0)
 ;;=1^J8530
 ;;^UTILITY(U,$J,358.3,20555,1,3,0)
 ;;=3^Cyclophosphamide Oral 25mg
 ;;^UTILITY(U,$J,358.3,20556,0)
 ;;=J9206^^116^1243^54^^^^1
 ;;^UTILITY(U,$J,358.3,20556,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20556,1,1,0)
 ;;=1^J9206
 ;;^UTILITY(U,$J,358.3,20556,1,3,0)
 ;;=3^Irinotecan Inj 20mg
 ;;^UTILITY(U,$J,358.3,20557,0)
 ;;=J0135^^116^1243^2^^^^1
 ;;^UTILITY(U,$J,358.3,20557,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20557,1,1,0)
 ;;=1^J0135
 ;;^UTILITY(U,$J,358.3,20557,1,3,0)
 ;;=3^Adalimumab Inj 20mg
 ;;^UTILITY(U,$J,358.3,20558,0)
 ;;=Q2050^^116^1243^37^^^^1
 ;;^UTILITY(U,$J,358.3,20558,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20558,1,1,0)
 ;;=1^Q2050
 ;;^UTILITY(U,$J,358.3,20558,1,3,0)
 ;;=3^Doxorubicin Inj 10mg
 ;;^UTILITY(U,$J,358.3,20559,0)
 ;;=J0129^^116^1243^1^^^^1
 ;;^UTILITY(U,$J,358.3,20559,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20559,1,1,0)
 ;;=1^J0129
 ;;^UTILITY(U,$J,358.3,20559,1,3,0)
 ;;=3^Abatacept Inj 10mg
 ;;^UTILITY(U,$J,358.3,20560,0)
 ;;=J0256^^116^1243^4^^^^1
 ;;^UTILITY(U,$J,358.3,20560,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20560,1,1,0)
 ;;=1^J0256
 ;;^UTILITY(U,$J,358.3,20560,1,3,0)
 ;;=3^Alpha 1 Proteinase Inh Inj 10mg
 ;;^UTILITY(U,$J,358.3,20561,0)
 ;;=J0461^^116^1243^7^^^^1
 ;;^UTILITY(U,$J,358.3,20561,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20561,1,1,0)
 ;;=1^J0461
 ;;^UTILITY(U,$J,358.3,20561,1,3,0)
 ;;=3^Atropine Sulfate Inj 0.01mg
 ;;^UTILITY(U,$J,358.3,20562,0)
 ;;=J0881^^116^1243^27^^^^1
 ;;^UTILITY(U,$J,358.3,20562,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20562,1,1,0)
 ;;=1^J0881
 ;;^UTILITY(U,$J,358.3,20562,1,3,0)
 ;;=3^Darbepoetin Alfa Inj 1mcg
 ;;^UTILITY(U,$J,358.3,20563,0)
 ;;=J1094^^116^1243^31^^^^1
 ;;^UTILITY(U,$J,358.3,20563,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20563,1,1,0)
 ;;=1^J1094
 ;;^UTILITY(U,$J,358.3,20563,1,3,0)
 ;;=3^Dexamethason Acetate Inj 1mg
 ;;^UTILITY(U,$J,358.3,20564,0)
 ;;=J1642^^116^1243^46^^^^1
 ;;^UTILITY(U,$J,358.3,20564,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20564,1,1,0)
 ;;=1^J1642
 ;;^UTILITY(U,$J,358.3,20564,1,3,0)
 ;;=3^Heparin Sodium Inj 10 Units
 ;;^UTILITY(U,$J,358.3,20565,0)
 ;;=J2405^^116^1243^72^^^^1
 ;;^UTILITY(U,$J,358.3,20565,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20565,1,1,0)
 ;;=1^J2405
 ;;^UTILITY(U,$J,358.3,20565,1,3,0)
 ;;=3^Ondansetron HCL Inj 1mg
 ;;^UTILITY(U,$J,358.3,20566,0)
 ;;=J2505^^116^1243^77^^^^1
 ;;^UTILITY(U,$J,358.3,20566,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20566,1,1,0)
 ;;=1^J2505
 ;;^UTILITY(U,$J,358.3,20566,1,3,0)
 ;;=3^Pegfilgrastim Inj 6mg
 ;;^UTILITY(U,$J,358.3,20567,0)
 ;;=J2780^^116^1243^82^^^^1
 ;;^UTILITY(U,$J,358.3,20567,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20567,1,1,0)
 ;;=1^J2780
